What if you'd held BBC?
A $1,000 investment in Virtus Biotech Clinical Trials ETF (BBC) at the month-end close of 2014-12 would be worth $2,115 at the close of 2026-08 — +111.5% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $3,744.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2014
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2014 | $1,000 | — |
| 2015 | $1,052 | +5.2% |
| 2016 | $667 | -36.6% |
| 2017 | $1,041 | +56.1% |
| 2018 | $851 | -18.3% |
| 2019 | $1,394 | +63.8% |
| 2020 | $1,816 | +30.3% |
| 2021 | $1,411 | -22.3% |
| 2022 | $915 | -35.1% |
| 2023 | $899 | -1.8% |
| 2024 | $889 | -1.1% |
| 2025 | $1,456 | +63.7% |
| 2026 | $2,115 | +45.3% |
Best and worst month-end to buy
The best single month-end close to have bought BBC was 2016-02 ($16.56): $1,000 then is $3,383 today. The worst was 2026-08 ($56.03): $1,000 then is $1,000.
FAQ
What would $1,000 in BBC be worth today?
A $1,000 investment in Virtus Biotech Clinical Trials ETF (BBC) at the start of 2014 would be worth about $2,115 today, a total return of +111.5%. Dividends are reinvested in these figures.
What were the best and worst years for BBC?
Virtus Biotech Clinical Trials ETF (BBC)'s strongest calendar year since 2014 was 2019, a +63.8% return — $1,000 held through that year became about $1,638 by year-end. Its weakest year was 2016, at -36.6%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in BBC have grown?
Investing $100 at the end of every month since 2014-12 would have grown to about $29,343 on $14,100 invested.
Did BBC beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $3,744. BBC trailed the S&P 500 by +43.5% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Virtus Biotech Clinical Trials ETF (BBC) historical total-return data from 2014-12 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.